. 2021 Jul 6;9(19):5082–5091. doi: 10.12998/wjcc.v9.i19.5082

Table 3.

Interval from exposure to diagnosis and treatments of five patients with acute thallium poisoning

Patient No.	Interval from exposure to diagnosis (d)	Time of receiving treatments after exposure				Duration of PB treatment (d)	Urine thallium concentration (µg/L)		Blood thallium concentration (µg/L)
Patient No.	Interval from exposure to diagnosis (d)	Sodium thiosulfate	DMPS	HP	PB	Duration of PB treatment (d)	Before treatment	After treatment	Before treatment	After treatment
1	9	3^rdday	12^th day	15^thday	15^thday	14	7200	160	280	0
2	8	3^rdday	10^thday	10^thday	11^thday	15	5100	130	210	0
3	11	10^thday	11^thday	15^thday	15^thday	15	250	0	150	0
4	12	11^thday	11^thday	15^thday	15^thday	14	370	0	40	0
5	12	11^thday	11^thday	15^thday	15^thday	16	580	0	46	0

The urine and blood samples were successively sent to Hospital 307 of Chinese People’s Liberation Army to confirm the diagnosis of acute thallium poisoning. The day when the patients underwent detoxification treatments after exposure is listed in the table. The Prussian blue (PB) treatment was implemented in Hospital 307 of Chinese People’s Liberation Army and lasted for 14 to 16 d. The urine and blood thallium concentration before and after PB treatment was recorded. Sodium thiosulfate: 0.64 g, intravenous injection per day; DMPS: Dimercaptopropane sulfonate 0.25 g, intramuscular injection twice daily; HP: Hemoperfusion; PB: Prussian blue 3.3 g in mannitol 50 mL, orally four times daily.